PATTERSON LEONE D — SEC insider filings

SEC reporting owner CIK 1233539. 21 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2021-02-11 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Adverum Biotechnologies, Inc. (ADVM)President and CFO2—2 legs · 12,533 sh · $176,7181
Tenaya Therapeutics, Inc. (TNYA)Chief Fin. and Bus. Officer5—2 legs · 9,653 sh · $47,4406
Nkarta, Inc. (NKTX)Director6——6
Zymeworks Inc. (ZYME)EVP, Chief Bus & Fin Officer3——4
Kalaris Therapeutics, Inc. (KLRS)Director2——2
Eliem Therapeutics, Inc. (ELYM)Director1——1
IRulya Therapeutics Inc. (IRLA)Director2——1

Insider filings — PATTERSON LEONE D

FiledFormIssuerReported transactionsSource
2026-11-124IRulya Therapeutics Inc. (IRLA)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2026-10-193IRulya Therapeutics Inc. (IRLA)Holdings only — no transactions reportedEDGAR
2026-06-114Nkarta, Inc. (NKTX)Grant/award (A): 37,000 (derivative) @ $0EDGAR
2026-06-044Kalaris Therapeutics, Inc. (KLRS)Grant/award (A): 9,000 (derivative) @ $0EDGAR
2026-01-074Zymeworks Inc. (ZYME)Grant/award (A): 459 @ $10.55EDGAR
2025-06-094Nkarta, Inc. (NKTX)Grant/award (A): 46,000 (derivative) @ $0EDGAR
2025-04-114Kalaris Therapeutics, Inc. (KLRS)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2025-01-104Zymeworks Inc. (ZYME)Grant/award (A): 79,000 (derivative) @ $0 · Grant/award (A): 53,000 (derivative) @ $0EDGAR
2024-09-034Zymeworks Inc. (ZYME)Grant/award (A): 360,000 (derivative) @ $0EDGAR
2024-06-144Nkarta, Inc. (NKTX)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2024-02-274Tenaya Therapeutics, Inc. (TNYA)Grant/award (A): 35,000 @ $0 · Grant/award (A): 205,000 (derivative) @ $0EDGAR
2024-02-164Tenaya Therapeutics, Inc. (TNYA)Sale (S): 5,201 @ $5.86EDGAR
2023-08-184Tenaya Therapeutics, Inc. (TNYA)Sale (S): 4,452 @ $3.81EDGAR
2023-06-094Nkarta, Inc. (NKTX)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2023-02-174Tenaya Therapeutics, Inc. (TNYA)Grant/award (A): 30,000 @ $0 · Grant/award (A): 35,000 @ $0 · Grant/award (A): 190,000 (derivative) @ $0EDGAR
2022-06-104Nkarta, Inc. (NKTX)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2022-06-014Eliem Therapeutics, Inc. (ELYM)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-02-174Tenaya Therapeutics, Inc. (TNYA)Grant/award (A): 66,000 (derivative) @ $0EDGAR
2021-06-154Nkarta, Inc. (NKTX)Grant/award (A): 16,511 (derivative) @ $0EDGAR
2021-02-184Adverum Biotechnologies, Inc. (ADVM)Grant/award (A): 240,000 (derivative) @ $0EDGAR
2021-02-114Adverum Biotechnologies, Inc. (ADVM)Sale (S): 12,471 @ $14.10 · Sale (S): 62 @ $14.14EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1233539 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs